These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 29410318)
1. Diacerein orphan drug development for epidermolysis bullosa simplex: A phase 2/3 randomized, placebo-controlled, double-blind clinical trial. Wally V; Hovnanian A; Ly J; Buckova H; Brunner V; Lettner T; Ablinger M; Felder TK; Hofbauer P; Wolkersdorfer M; Lagler FB; Hitzl W; Laimer M; Kitzmüller S; Diem A; Bauer JW J Am Acad Dermatol; 2018 May; 78(5):892-901.e7. PubMed ID: 29410318 [TBL] [Abstract][Full Text] [Related]
2. Topical diacerein for epidermolysis bullosa: a randomized controlled pilot study. Wally V; Kitzmueller S; Lagler F; Moder A; Hitzl W; Wolkersdorfer M; Hofbauer P; Felder TK; Dornauer M; Diem A; Eiler N; Bauer JW Orphanet J Rare Dis; 2013 May; 8():69. PubMed ID: 23651789 [TBL] [Abstract][Full Text] [Related]
3. Topical Diacerein Ointment for Epidermolysis Bullosa Simplex: A Review. Limmer AL; Nwannunu CE; Shah R; Coleman K; Patel RR; Mui UN; Tyring SK Skin Therapy Lett; 2019 May; 24(3):7-9. PubMed ID: 31095348 [TBL] [Abstract][Full Text] [Related]
4. Basal pharmacokinetic parameters of topically applied diacerein in pediatric patients with generalized severe epidermolysis bullosa simplex. Ablinger M; Felder TK; Wimmer M; Zauner R; Hofbauer P; Lettner T; Wolkersdorfer M; Lagler FB; Diem A; Bauer JW; Wally V Orphanet J Rare Dis; 2018 Nov; 13(1):193. PubMed ID: 30382914 [TBL] [Abstract][Full Text] [Related]
5. The efficacy and safety of diacerein in the treatment of painful osteoarthritis of the knee: a randomized, multicenter, double-blind, placebo-controlled study with primary end points at two months after the end of a three-month treatment period. Pavelka K; Trc T; Karpas K; Vítek P; Sedlácková M; Vlasáková V; Böhmová J; Rovenský J Arthritis Rheum; 2007 Dec; 56(12):4055-64. PubMed ID: 18050202 [TBL] [Abstract][Full Text] [Related]
6. Diacerein for the treatment of rheumatoid arthritis in patients with inadequate response to methotrexate: a pilot randomized, double-blind, placebo-controlled add-on trial. Louthrenoo W; Nilganuwong S; Nanagara R; Siripaitoon B; Collaud Basset S Clin Rheumatol; 2019 Sep; 38(9):2461-2471. PubMed ID: 31104217 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of the structure-modifying effects of diacerein in hip osteoarthritis: ECHODIAH, a three-year, placebo-controlled trial. Evaluation of the Chondromodulating Effect of Diacerein in OA of the Hip. Dougados M; Nguyen M; Berdah L; Maziéres B; Vignon E; Lequesne M; Arthritis Rheum; 2001 Nov; 44(11):2539-47. PubMed ID: 11710710 [TBL] [Abstract][Full Text] [Related]
8. A global, cross-sectional survey of patient-reported outcomes, disease burden, and quality of life in epidermolysis bullosa simplex. So JY; Fulchand S; Wong CY; Li S; Nazaroff J; Gorell ES; de Souza MP; Murrell DF; Teng JM; Chiou AS; Tang JY Orphanet J Rare Dis; 2022 Jul; 17(1):270. PubMed ID: 35841105 [TBL] [Abstract][Full Text] [Related]
9. Transcriptomic Repositioning Analysis Identifies mTOR Inhibitor as Potential Therapy for Epidermolysis Bullosa Simplex. Lee GH; Lekwuttikarn R; Tafoya E; Martin M; Sarin KY; Teng JM J Invest Dermatol; 2022 Feb; 142(2):382-389. PubMed ID: 34536484 [TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of diacerein in early knee osteoarthritis: a randomized placebo-controlled trial. Brahmachari B; Chatterjee S; Ghosh A Clin Rheumatol; 2009 Oct; 28(10):1193-8. PubMed ID: 19597913 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of diacerein in reducing liver steatosis and fibrosis in patients with type 2 diabetes and non-alcoholic fatty liver disease: A randomized, placebo-controlled trial. Leite NC; Viegas BB; Villela-Nogueira CA; Carlos FO; Cardoso CRL; Salles GF Diabetes Obes Metab; 2019 May; 21(5):1266-1270. PubMed ID: 30687994 [TBL] [Abstract][Full Text] [Related]
12. The efficacy of diacerein in hand osteoarthritis: a double-blind, randomized, placebo-controlled study. Shin K; Kim JW; Moon KW; Yang JA; Lee EY; Song YW; Lee EB Clin Ther; 2013 Apr; 35(4):431-9. PubMed ID: 23474153 [TBL] [Abstract][Full Text] [Related]
13. Tetracycline and epidermolysis bullosa simplex: a double-blind, placebo-controlled, crossover randomized clinical trial. Weiner M; Stein A; Cash S; de Leoz J; Fine JD Br J Dermatol; 2004 Mar; 150(3):613-4. PubMed ID: 15030362 [No Abstract] [Full Text] [Related]
14. Diacerein as adjuvant to diclofenac sodium in osteoarthritis knee. Singh K; Sharma R; Rai J Int J Rheum Dis; 2012 Feb; 15(1):69-77. PubMed ID: 22324949 [TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of diacerein in osteoarthritis of the knee: a double-blind, placebo-controlled trial. The Diacerein Study Group. Pelletier JP; Yaron M; Haraoui B; Cohen P; Nahir MA; Choquette D; Wigler I; Rosner IA; Beaulieu AD Arthritis Rheum; 2000 Oct; 43(10):2339-48. PubMed ID: 11037895 [TBL] [Abstract][Full Text] [Related]
16. Randomized, split-body, single-blinded clinical trial of topical broccoli sprout extract: Assessing the feasibility of its use in keratin-based disorders. Kerns ML; Guss L; Fahey J; Cohen B; Hakim JM; Sung S; Lu RG; Coulombe PA J Am Acad Dermatol; 2017 Mar; 76(3):449-453.e1. PubMed ID: 27889290 [TBL] [Abstract][Full Text] [Related]